• Flash Briefings and Podcasts

  How Risdiplam Defies SMA “Natural History” in Type 1 Infants, According to FIREFISH Study Data

  Posted by sma-news-today-moderator on May 11, 2020 at 8:59 am

  

  Forums moderator DeAnn Runge shares her experience of getting Spinraza amidst the COVID pandemic.

  SMA News Today’s multimedia associate, Price Wooldridge, discusses how Risdiplam defies SMA “natural history” in type 1 infants, according to FIREFISH study data.

  https://soundcloud.com/sma-news-today/how-risdiplam-defies-sma-natural-history-in-type-1-infants-according-to-firefish-study-data

  Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

   

  sma-news-today-moderator replied 3 years, 11 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply